Microvascular Angina Clinical Trials
3 recruiting trials for Microvascular Angina. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Microvascular Angina clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Samsung Medical Center (1), VahatiCor, Inc. (1), Royal United Hospitals Bath NHS Foundation Trust (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is CMD test (diagnostic_test, 1 trial), followed by A-FLUX Reducer System, MICROFIT - personalised high intensity interval training exercise rehabilitation and dietary advice.
Track Microvascular Angina trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in...
This study aims to evaluate the incidence of coronary microvascular dysfunction (CMD) and its prognostic implication for the improvement of left ventricular function in patients...
Self Expanding Coronary Sinus Reducer for Treatment of Symptomatic Coronary Microvascular Dysfunction (CMD)
VahatiCor's Coronary Sinus Reducer (A-FLUX) has been designed to improve angina or angina-like symptoms in patients with CMD. SERRA-I is an early feasibility study that evaluates...
Microvascular Coronary Rehabilitation For Improving Treatment - Feasibility Study
The goal of this clinical trial is to assess the feasibility of undertaking a randomized controlled trial assessing the impact of a personalised, intense cardiac rehabilitation...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Microvascular Angina, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Microvascular Angina, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Microvascular Angina, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.